Evidence map›Paper›PMID 41354757›Full record

ArticleScientific reports2025

Intelligent retinal disease detection using deep learning.

Shereen A Hussein, Ahd A Farouk, Mary Monir Saeid

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shereen A HusseinDepartment of Computer Science, Faculty of Computers and Artificial Intelligence, Fayoum University, Fayoum, Egypt. Sam26@fayoum.edu.eg.
Ahd A FaroukDepartment of Computer Science, Faculty of Computers and Artificial Intelligence, Fayoum University, Fayoum, Egypt.
Mary Monir SaeidDepartment of Computer Science, Faculty of Computers and Artificial Intelligence, Fayoum University, Fayoum, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising prevalence of retinal diseases is a significant concern, as certain untreated conditions can lead to severe vision impairment or even blindness. Deep learning algorithms have emerged as a powerful tool for the diagnosis and analysis of medical images. The automated detection of retinal diseases not only aids ophthalmologists in making accurate clinical decisions but also enhances efficiency by saving time. This study proposes a deep learning-based approach for the automated classification of multiple retinal diseases using fundus images. For this research, a balanced dataset was compiled by integrating data from various sources. Artificial Neural Networks (ANN) and transfer learning techniques were utilized to differentiate between healthy eyes and those affected by diabetic retinopathy, cataracts, or glaucoma. Multiple feature extraction methods were employed in conjunction with ANN for the multi-classification of retinal diseases. The results demonstrate that the model combining Artificial Neural Networks (ANN) with MobileNetV2 and DenseNet121 architectures, along with Principal Component Analysis (PCA) for feature extraction and dimensionality reduction, as well as the Discrete Wavelet Transform (DWT) algorithm, achieves highly satisfactory performance, attaining a peak accuracy of 98.2%.

Indexed as

Deep LearningRetinal DiseasesAlgorithmsDiabetic RetinopathyGlaucomaHumansImage Processing, Computer-AssistedNeural Networks, ComputerPrincipal Component AnalysisArtificial neural networkClassificationFundus imagesMedical image diagnosisPre-defined modelRetinal diseases

Identifiers

PMID41354757
PMCPMC12686508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.